COMMISSION IMPLEMENTING REGULATION (EU) 2021/2049
of 24 November 2021
renewing the approval of the active substance cypermethrin as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
(Text with EEA relevance)
Article 1
Renewal of the approval of the active substance
Article 2
Amendments to Implementing Regulation (EU) No 540/2011
Article 3
Entry into force and date of application
ANNEX I
Common Name, Identification Numbers |
IUPAC Name |
Purity(1) |
Date of approval |
Expiration of approval |
Specific provisions |
||||||||||||||||||||||||
Cypermethrin CAS No 52315-07-8 CIPAC No 332 |
(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate or (RS)-α-cyano-3-phenoxybenzyl-(1RS)-cis-trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
920 g/kg cis:trans: 40/60 to 60/40 The following impurities are of toxicological concern and must not exceed the following levels in the technical material: hexane: 5g/kg |
1 February 2022 |
31 January 2029 |
Authorisations shall be limited to professional users. When authorising plant protection products containing cypermethrin for spray applications outdoors, in order to ensure the protection of non-target organisms, in particular aquatic organisms and non-target arthropods, including bees:
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on cypermethrin, and in particular Appendices I and II thereto, shall be taken into account. Member States shall pay particular attention to:
Where considered appropriate, Member States shall set monitoring requirements when granting authorisations in accordance with Article 6(i) of the Regulation (EC) No 1107/2009, in order to complement the monitoring under Directives of the European Parliament and of the Council 2000/60/EC(2) and 2009/128/EC(3). The applicant shall submit to the Commission, the Member States and the Authority confirmatory information as regards:
The applicant shall submit:
As regards Points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as amended by Regulation (EU) 2018/605 an updated assessment of the information already submitted and, where relevant, further information to confirm the absence of endocrine activity shall be submitted by 15 December 2023. |
ANNEX II
‘14 |
Cypermethrin CAS No 52315-07-8 CIPAC No 332 |
(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate or (RS)-α-cyano-3-phenoxybenzyl-(1RS)-cis-trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
920 g/kg cis:trans: 40/60 to 60/40 The following impurities are of toxicological concern and must not exceed the following levels in the technical material: hexane: 5g/kg |
1 February 2022 |
31 January 2029 |
Authorisations shall be limited to professional users. When authorising plant protection products containing cypermethrin for spray applications outdoors, in order to ensure the protection of non-target organisms, in particular aquatic organisms and non-target arthropods, including bees:
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on cypermethrin, and in particular Appendices I and II thereto, shall be taken into account. Member States shall pay particular attention to:
Where considered appropriate, Member States shall set monitoring requirements when granting authorisations in accordance with Article 6(i) of the Regulation (EC) No 1107/2009, in order to complement the monitoring under Directives of the European Parliament and of the Council 2000/60/EC (*1) and 2009/128/EC (*2). The applicant shall submit to the Commission, the Member States and the Authority confirmatory information as regards:
The applicant shall submit:
As regards Points 3.6.5 and 3.8.2 of Annex II toRegulation (EC) No 1107/2009, as amended by Regulation (EU) 2018/605 an updated assessment of the information already submitted and, where relevant, further information to confirm the absence of endocrine activity shall be submitted by 15 December 2023. |